Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial

In Vitro Activity of Lefamulin against S. aureus Collected Worldwide from Hospitalized Patients with Bacterial Pneumonia

1217. In Vitro Activity of Ceftolozane-Tazobactam vs. Antimicrobial NonSusceptible Pseudomonas aeruginosa Clinical Isolates Obtained from Across Canada as Part of the CANWARD Study, 2008–2016 Andrew Walkty, MD; Heather J. Adam, PhD; Melanie Baxter, MSc; Philippe Lagace-Wiens, MD; James Karlowsky, PhD; Daryl Hoban, PhD and George Zhanel, PhD; Diagnostic Services Manitoba, Winnipeg, MB, Canada, M...

In Vitro Activity of Lefamulin Against a Global Collection of Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP, SENTRY 2015)

Management of community acquired pneumonia.

P is a common illness which causes significant morbidity and mortality all over the world, despite the availability of better and more potent antibiotics and improvement in supportive care. The problem increases with discrepancy in management despite the availability of guidelines for management. Pneumonia is often misdiagnosed and is commonly treated inadequately or over treated with misuse of...

evaluation and management of community and hospital-acquired pneumonia for the primary care providers

conclusions cap/hap remains one of the leading causes of morbidity and mortality in the world. bacterial resistance is increasing and adds to the difficulty in treating these patients. newer drugs are available but should be used judiciously and in the right setting. context the incidence and prevalence of both community and hospital acquired pneumonia has remained relatively constant over the ...

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

Ceftaroline fosamil (ceftaroline) was recently approved for the treatment of community- acquired pneumonia (CAP) and complicated skin infections. This newly developed cephalosporin possesses a broad spectrum of activity against gram-positive and gram-negative bacteria. Most importantly, ceftaroline demonstrates potent in vitro antimicrobial activity against multi-drug resistant Streptococcus pn...